MENU
EYPT
AS OF
Feb 4, 04:46 PM (EDT)
Price
$12.40
Change
-$0.40 (-3.12%)
Capitalization
1.06B
29 days until earnings call
Intraday BUY SELL Signals
+Compare
EYPT
Stock ticker: NASDAQ
AS OF
Feb 4, 04:46 PM (EDT)
Price
$12.40
Change
-$0.40 (-3.12%)
Capitalization
1.06B

EYPT EyePoint Inc. Forecast, Technical & Fundamental Analysis

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases... Show more

EYPT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for EYPT with price predictions
Feb 03, 2026

EYPT's Indicator enters downward trend

The Aroon Indicator for EYPT entered a downward trend on February 03, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 300 similar instances where the Aroon Indicator formed such a pattern. In of the 300 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EYPT as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for EYPT turned negative on December 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

EYPT moved below its 50-day moving average on January 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EYPT crossed bearishly below the 50-day moving average on January 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EYPT advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

EYPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EYPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.294) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (20.747) is also within normal values, averaging (331.843).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
EYPT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EYPT is expected to report earnings to fall 12.04% to -74 cents per share on March 05

EyePoint Inc. EYPT Stock Earnings Reports
Q4'25
Est.
$-0.75
Q3'25
Missed
by $0.08
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.14
The last earnings report on November 05 showed earnings per share of -85 cents, missing the estimate of -76 cents. With 69.61K shares outstanding, the current market capitalization sits at 1.06B.
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 617 926-5000
Employees
121
Web
https://www.eyepointpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SRECX13.870.09
+0.65%
PGIM Select Real Estate C
GWGIX20.380.04
+0.20%
AMG GW&K Small Mid Cap Core I
FLACX89.86N/A
N/A
Fidelity Advisor Stock Sel C
LMOIX39.86-0.14
-0.35%
ClearBridge Small Cap Growth IS
PSEPX20.20-0.09
-0.44%
1789 Growth and Income P

EYPT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-3.69%
OCUL - EYPT
64%
Loosely correlated
-6.99%
LYRA - EYPT
58%
Loosely correlated
-1.98%
ATHE - EYPT
54%
Loosely correlated
-2.87%
CRSP - EYPT
49%
Loosely correlated
+1.34%
IDYA - EYPT
47%
Loosely correlated
+0.50%
More